Vercauteren DP - Search Results

1

Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme.

Wouters J, Moureau F, Vercauteren DP, Evrard G, Durant F, Koenig JJ, Ducrey F, Jarreau FX. Wouters J, et al. Among authors: vercauteren dp. J Neural Transm Suppl. 1994;41:313-9. doi: 10.1007/978-3-7091-9324-2_41. J Neural Transm Suppl. 1994. PMID: 7931244

2

Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonist.

Collin S, Evrard G, Vercauteren DP, Durant F, Carrupt PA, van de Waterbeemd H, Testa B. Collin S, et al. Among authors: vercauteren dp. J Med Chem. 1989 Jan;32(1):38-42. doi: 10.1021/jm00121a008. J Med Chem. 1989. PMID: 2521253

3

Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligands.

Collin S, Vercauteren DP, Vanderveken D, Evrard G, Durant F. Collin S, et al. Among authors: vercauteren dp. J Comput Aided Mol Des. 1989 Mar;3(1):39-53. doi: 10.1007/BF01590994. J Comput Aided Mol Des. 1989. PMID: 2715795

4

3- and 5-isoxazolol zwitterions: an ab initio molecular orbital study relating to GABA agonism and antagonism.

Boulanger T, Vercauteren DP, Durant F, Andre JM. Boulanger T, et al. Among authors: vercauteren dp. J Theor Biol. 1987 Aug 21;127(4):479-89. doi: 10.1016/s0022-5193(87)80144-3. J Theor Biol. 1987. PMID: 2832660

5

Structure and molecular modeling of GABAA receptor antagonists.

Rognan D, Boulanger T, Hoffmann R, Vercauteren DP, Andre JM, Durant F, Wermuth CG. Rognan D, et al. Among authors: vercauteren dp. J Med Chem. 1992 May 29;35(11):1969-77. doi: 10.1021/jm00089a005. J Med Chem. 1992. PMID: 1317920

6

Description of non-covalent interactions in benzyl chalcocyanate crystals from smoothed Cromer-Mann electron density distribution functions.

Leherte L, Bodart L, Wouters J, Vercauteren DP. Leherte L, et al. Among authors: vercauteren dp. J Phys Condens Matter. 2022 Oct 26;34(49). doi: 10.1088/1361-648X/ac99c9. J Phys Condens Matter. 2022. PMID: 36223781

7

Comparison of benzodiazepine-like compounds using topological analysis and genetic algorithms.

Meurice N, Leherte L, Vercauteren DP. Meurice N, et al. Among authors: vercauteren dp. SAR QSAR Environ Res. 1998;8(3-4):195-232. doi: 10.1080/10629369808039141. SAR QSAR Environ Res. 1998. PMID: 9522475 Review.

8

Can descriptors of the electron density distribution help to distinguish functional groups?

Burton J, Meurice N, Leherte L, Vercauteren DP. Burton J, et al. Among authors: vercauteren dp. J Chem Inf Model. 2008 Oct;48(10):1974-83. doi: 10.1021/ci800148z. Epub 2008 Oct 3. J Chem Inf Model. 2008. PMID: 18831545

9

Critical point representations of electron density maps for the comparison of benzodiazepine-type ligands.

Leherte L, Meurice N, Vercauteren DP. Leherte L, et al. Among authors: vercauteren dp. J Chem Inf Comput Sci. 2000 May-Jun;40(3):816-32. doi: 10.1021/ci990112d. J Chem Inf Comput Sci. 2000. PMID: 10850788

10

Use of electron density critical points as chemical function-based reduced representations of pharmacological ligands.

Binamé J, Meurice N, Leherte L, Glasgow J, Fortier S, Vercauteren DP. Binamé J, et al. Among authors: vercauteren dp. J Chem Inf Comput Sci. 2004 Jul-Aug;44(4):1394-401. doi: 10.1021/ci034157x. J Chem Inf Comput Sci. 2004. PMID: 15272847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters